Ming Zhuang

933 total citations
31 papers, 760 citations indexed

About

Ming Zhuang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ming Zhuang has authored 31 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ming Zhuang's work include Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (4 papers). Ming Zhuang is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (7 papers) and MicroRNA in disease regulation (4 papers). Ming Zhuang collaborates with scholars based in China, United States and South Africa. Ming Zhuang's co-authors include Jing Xu, Ping Wang, Wen Gao, Yongqian Shu, Dong Cheng, Chenlei Zhu, Zhiwei Liu, Xingnan Zheng, Peng Yang and Zhuoyu Li and has published in prestigious journals such as Cancer Research, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Ming Zhuang

29 papers receiving 756 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Zhuang China 15 559 389 112 87 66 31 760
Heiwa Okuda Japan 14 499 0.9× 356 0.9× 97 0.9× 109 1.3× 92 1.4× 20 703
Nobuhiko Sugito Japan 22 958 1.7× 771 2.0× 109 1.0× 103 1.2× 41 0.6× 36 1.2k
Meimei Wan United States 16 659 1.2× 306 0.8× 117 1.0× 68 0.8× 59 0.9× 21 915
Hongxing Shen United States 13 400 0.7× 353 0.9× 119 1.1× 36 0.4× 41 0.6× 22 672
Raúl Peña Spain 12 769 1.4× 535 1.4× 313 2.8× 61 0.7× 58 0.9× 17 1.0k
Sajjeev Jagannathan United States 11 525 0.9× 260 0.7× 119 1.1× 66 0.8× 68 1.0× 22 735
Nuri Oh South Korea 13 409 0.7× 166 0.4× 129 1.2× 55 0.6× 42 0.6× 22 754
Xuexia Zhou China 17 779 1.4× 469 1.2× 76 0.7× 42 0.5× 23 0.3× 30 908
Zerong Cai China 10 1.0k 1.8× 750 1.9× 125 1.1× 77 0.9× 54 0.8× 25 1.2k

Countries citing papers authored by Ming Zhuang

Since Specialization
Citations

This map shows the geographic impact of Ming Zhuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhuang more than expected).

Fields of papers citing papers by Ming Zhuang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Zhuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhuang. The network helps show where Ming Zhuang may publish in the future.

Co-authorship network of co-authors of Ming Zhuang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhuang. A scholar is included among the top collaborators of Ming Zhuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhuang. Ming Zhuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Yuqing, Ming Zhuang, Zheping Huang, et al.. (2024). An antihypertensive drug-AT1 inhibitor attenuated BRCA development promoted by chronic psychological stress via Ang II/PARP1/FN1 pathway. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(3). 167031–167031. 3 indexed citations
2.
Yuan, Xiaofeng, Ming Zhuang, Xi Zhu, et al.. (2022). Emerging Perspectives of Bone Metastasis in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 943866–943866. 9 indexed citations
3.
Yuan, Xiaofeng, Lianhua Piao, Jiawen Wang, et al.. (2022). Cellular functions and molecular mechanisms of ubiquitination in osteosarcoma. Frontiers in Oncology. 12. 1072701–1072701. 2 indexed citations
4.
Zhuang, Ming, Shan Jiang, Anxin Gu, Xuesong Chen, & E Mingyan. (2021). Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer. Translational Oncology. 14(12). 101210–101210. 15 indexed citations
5.
Jiang, Shan, Zhao Liu, Yuhang Tian, et al.. (2021). A Comprehensive Evaluation of ZrC Nanoparticle in Combined Photothermal and Radiation Therapy for Treatment of Triple-Negative Breast Cancer. Frontiers in Oncology. 11. 801352–801352. 9 indexed citations
6.
Chen, Deqin, Yike Wang, Jingpei Long, et al.. (2021). Downregulation of long non‑coding RNA MR4435‑2HG suppresses breast cancer progression via the Wnt/β‑catenin signaling pathway. Oncology Letters. 21(5). 373–373. 19 indexed citations
7.
Piao, Lianhua, Xiaofeng Yuan, Luhui Wang, et al.. (2020). Loss of histone H4 lysine 20 trimethylation in osteosarcoma is associated with aberrant expression ofhistone methyltransferase SUV420H2. Oncology Letters. 20(4). 26–26. 9 indexed citations
8.
Zhuang, Ming, Ziwen Lu, Zhiwei Liu, et al.. (2019). RIPK1 suppresses apoptosis mediated by TNF and caspase-3 in intervertebral discs. Journal of Translational Medicine. 17(1). 135–135. 20 indexed citations
10.
Zhuang, Ming, et al.. (2018). MicroRNA-524 promotes cell proliferation by down-regulating PTEN expression in osteosarcoma. Cancer Cell International. 18(1). 114–114. 37 indexed citations
11.
Takada, Mamoru, Weiguo Zhang, Aussie Suzuki, et al.. (2017). FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2–Mediated Phosphorylation of CENP-A. Cancer Research. 77(18). 4881–4893. 67 indexed citations
12.
Liu, Zhiwei, Lianhua Piao, Ming Zhuang, et al.. (2017). Silencing of histone methyltransferase NSD3 reduces cell viability in osteosarcoma with induction of apoptosis. Oncology Reports. 38(5). 2796–2802. 25 indexed citations
13.
Cheng, Dong, et al.. (2017). MicroRNAs with prognostic significance in osteosarcoma: a systemic review and meta-analysis. Oncotarget. 8(46). 81062–81074. 25 indexed citations
14.
Li, Zongwei, Ming Zhuang, Lichao Zhang, et al.. (2016). Acetylation modification regulates GRP78 secretion in colon cancer cells. Scientific Reports. 6(1). 30406–30406. 54 indexed citations
15.
Zhuang, Ming, Wen Gao, Jing Xu, Ping Wang, & Yongqian Shu. (2014). The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochemical and Biophysical Research Communications. 448(3). 315–322. 183 indexed citations
16.
Zhuang, Ming, Qin Shi, Xiuwei Zhang, et al.. (2014). Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2. Tumor Biology. 36(4). 2737–2745. 48 indexed citations
17.
Lv, Min, Yan Li, Minghua Ji, Ming Zhuang, & Jinhai Tang. (2014). Inhibition of invasion and epithelial-mesenchymal transition of human breast cancer cells by hydrogen sulfide through decreased phospho-p38 expression. Molecular Medicine Reports. 10(1). 341–346. 41 indexed citations
18.
Zhu, Jian, Bingfeng Chu, Yipeng Yang, et al.. (2013). B7-H4 Expression is Associated with Cancer Progression and Predicts Patient Survival in Human Thyroid Cancer. Asian Pacific Journal of Cancer Prevention. 14(5). 3011–3015. 25 indexed citations
19.
Zhao, Zekun, Ping Dong, Jun Gu, et al.. (2012). Overexpression of LSD1 in hepatocellular carcinoma: a latent target for the diagnosis and therapy of hepatoma. Tumor Biology. 34(1). 173–180. 42 indexed citations
20.
Zhuang, Ming. (2012). Retrieval-balloon-assisted enterography in post-pancreaticoduodenectomy endoscopic retrograde cholangiopancreatography. World Journal of Gastroenterology. 18(47). 7109–7109. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026